These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4218012)

  • 61. [Construction of new types of chemical vaccines for the prevention of intestinal infections, and their qualitative assessment. IV. Physical properties and immunological characteristics of the experimental series of chemical vaccines presented for comparative study].
    Andrievskaia RA; Karpukhin GI; Luk'ianova EG; Dudkina MI; Shapiro NI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jul; (7):24-30. PubMed ID: 766526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Typhoid and paratyphoid fever in Swedish travellers abroad--why do we vaccinate].
    Grillner L; Iwarson S
    Lakartidningen; 1974 Nov; 71(48):4931-2. PubMed ID: 4218289
    [No Abstract]   [Full Text] [Related]  

  • 63. [Prevention of salmonellosis].
    Wone I; de Lauture H
    Dakar Med; 1979; 24(1):47-50. PubMed ID: 115666
    [No Abstract]   [Full Text] [Related]  

  • 64. [Use of the keratoconjunctival model in guinea pigs for quantitative assessment of the immunogenicity of dysentery antigens].
    Korneeva SA; Solov'eva OG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):139-40. PubMed ID: 335731
    [No Abstract]   [Full Text] [Related]  

  • 65. [In vitro susceptibility of typhoid, paratyphoid and dysentery bacilli to aureomycin and chloramphenicol].
    ALIN K; WALLMARK G
    Nord Med; 1950 Apr; 43(16):663-4. PubMed ID: 14796936
    [No Abstract]   [Full Text] [Related]  

  • 66. [The role of the interval between vaccinations with anti-dysenteric polyvalent vaccines and with combined typhoid-dysentery-tetanus vaccines].
    RAUSS K; RETHY L; KETYI I; JOO I
    Arch Belg Med Soc; 1959 Jun; 17():433-46. PubMed ID: 14436511
    [No Abstract]   [Full Text] [Related]  

  • 67. An update on Shigella vaccines.
    Ashkenazi S; Cohen D
    Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Typhoid-paratyphoid endotoxin in prevention of typhoid infections. Application and results of 15 years of vaccination (1934-1948)].
    GRASSET E
    Rev Immunol Ther Antimicrob; 1951; 15(1-2):1-19. PubMed ID: 14865368
    [No Abstract]   [Full Text] [Related]  

  • 69. [Simultaneous immunization with TABTe, tick-borne encephalitis, smallpox, tularemia, influenza and BCG vaccines].
    Aksenenko GR
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Dec; 48(12):41-5. PubMed ID: 5002398
    [No Abstract]   [Full Text] [Related]  

  • 70. Typhoid and paratyphoid fever - prevention in travellers.
    Mayer CA; Neilson AA
    Aust Fam Physician; 2010 Nov; 39(11):847-51. PubMed ID: 21301658
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modern vaccines. Enteric infections.
    Levine MM
    Lancet; 1990 Apr; 335(8695):958-61. PubMed ID: 1970034
    [No Abstract]   [Full Text] [Related]  

  • 72. [Immunogenicity of typhoid and paratyphoid B components of divaccine when used orally (an experimental study)].
    Ianisker GIa; Faĭn VI; Meshalova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):73-7. PubMed ID: 4980673
    [No Abstract]   [Full Text] [Related]  

  • 73. [Design of new types of chemical vaccines for the prevention of intestinal infections and problems of their qualitative evaluation. Report 2. Immunochemical characteristics of the experimental preparations].
    Vasil'eva TG; Shapiro NI; Sazonets GI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):29-34. PubMed ID: 1221723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The prevention of intestinal anthroponoses among military personnel].
    Korol'kov VF; Ogarkov PI; Mandrik VA
    Voen Med Zh; 1992; (4-5):71-4. PubMed ID: 1523823
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
    [No Abstract]   [Full Text] [Related]  

  • 76. [Experimental method using bacteremia as an index to evaluate the potency of typhoid vaccines].
    Cabrera Contreras R; González Pacheco M; Pérez-Miravete A
    Rev Invest Salud Publica; 1973; 33(3-4):83-97. PubMed ID: 4793810
    [No Abstract]   [Full Text] [Related]  

  • 77. [Use of the phage titer increase methods in qualitative control of disinfection in foci of intestinal infections (typhoid fever, dysentery)].
    KOZEL'KO OA
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Feb; 32():36-9. PubMed ID: 13753754
    [No Abstract]   [Full Text] [Related]  

  • 78. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combined TAB vaccine.
    Werner SB
    JAMA; 1973 Mar; 223(10):1158. PubMed ID: 4631405
    [No Abstract]   [Full Text] [Related]  

  • 80. Vaccines against cholera, typhoid fever and shigellosis for developing countries.
    Acosta CJ; Galindo CM; Deen J; Ochiai R; Lee HJ; von Seidlein L; Carbis R; Clemens JD
    Expert Opin Biol Ther; 2004 Dec; 4(12):1939-51. PubMed ID: 15571456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.